DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
NCT ID: NCT00389675
Last Updated: 2014-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
661 participants
INTERVENTIONAL
2007-05-31
2010-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension
NCT00353574
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
NCT06307652
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure
NCT03036124
Use of Dapagliflozin to Reduce Burden of Atrial Fibrillation in Patients Undergoing Catheter Ablation of Symptomatic Atrial Fibrillation
NCT04792190
Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).
NCT00159627
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Darusentan
Darusentan capsules titrated to an optimal dose of 50 mg, 100 mg, or 300 mg administered orally once daily
Darusentan
Darusentan capsules at a dose of 50, 100, or 300 mg administered orally once daily
Guanfacine
Guanfacine 1 mg capsules administered orally once daily
Guanfacine
Guanfacine 1 mg capsules administered orally once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Darusentan
Darusentan capsules at a dose of 50, 100, or 300 mg administered orally once daily
Guanfacine
Guanfacine 1 mg capsules administered orally once daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Subjects must have completed the Maintenance Period of the DAR-312 study.
Exclusion Criteria
2. Subjects who experience a study drug-related serious adverse event (SAE) during the DAR-312 study.
35 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gilead Sciences
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alabama Internal Medicine, PC
Birmingham, Alabama, United States
Greystone Medical Research, LLC
Birmingham, Alabama, United States
The Heart Center, PC
Huntsville, Alabama, United States
Mulberry Medical Associates, PC
Montgomery, Alabama, United States
Arizona Center for Clinical Research
Glendale, Arizona, United States
Cardiovascular Consultants, Ltd.
Glendale, Arizona, United States
Lovelace Scientific Resource, Inc.
Phoenix, Arizona, United States
Cochise Clinical Research
Sierra Vista, Arizona, United States
Southwest Heart
Tucson, Arizona, United States
HealthFirst Physicians of AR, PA dba Convenient Care Clinic
Hot Springs, Arkansas, United States
NEA Clinical
Jonesboro, Arkansas, United States
Arkansas Primary Care Clinic, PA
Little Rock, Arkansas, United States
Medical Investigators, Inc.
Little Rock, Arkansas, United States
Highgrove Medical Center
Bakersfield, California, United States
Central Cardiology Medical Clinic
Bakersfield, California, United States
Impact Clinical Trials
Beverly Hills, California, United States
VA Greater Los Angeles Healthcare System
Los Angeles, California, United States
Rancho Cucamonga Clinical Trials
Rancho Cucamonga, California, United States
Pacific Heart Institute
Santa Monica, California, United States
Los angeles biomedical research Institute at Harbor-UCLA Medical Center
Torrance, California, United States
Aurora Denver Cardiology Associates
Aurora, Colorado, United States
Aurora Denver Cardiology Associates
Denver, Colorado, United States
Clinical Research of South Florida
Coral Gables, Florida, United States
Doctors Medical center of Walton County
DeFuniak Springs, Florida, United States
Broward General Medical Center
Fort Lauderdale, Florida, United States
Maxine Hamilton, MD, PA
Fort Lauderdale, Florida, United States
St John's Center for Clinical Research
Jacksonville, Florida, United States
Private Practice of Dr. Bridget Bellingar
Largo, Florida, United States
A + Research Inc.
Miami, Florida, United States
AppleMed Research, Inc.
Miami, Florida, United States
Internal Medicine Associates of South Florida
North Miami Beach, Florida, United States
Ormond Medical Arts Pharmaceutical Research Center
Ormond Beach, Florida, United States
Nothwest Florida Heart Group, PA-Research Dept
Pensacola, Florida, United States
Cardiovascular Center of Sarasota
Sarasota, Florida, United States
Suncoast Cardiovascular Research, Inc
St. Petersburg, Florida, United States
Tampa Bay Nephrology Associates, PL
Tampa, Florida, United States
Orlando Rangel, MD, PA
Tampa, Florida, United States
AMR Research Associates, LLC
Bogart, Georgia, United States
Atlanta Vascular Research Foundation
Tucker, Georgia, United States
Consultants in Cardiovascular Med (CIS)
Melrose Park, Illinois, United States
Illinois Heart & Lunch Research Center
Normal, Illinois, United States
Methodist Medical Center-Heart, Lung & Vascular Institute
Peoria, Illinois, United States
Medical consultants, PC
Muncie, Indiana, United States
University Medical Associates
Louisville, Kentucky, United States
Dr. Jeffrey Chen
Lafayette, Louisiana, United States
Louisiana Research Associates, Inc.
New Orleans, Louisiana, United States
Maine Research Associates
Auburn, Maine, United States
PrimeCare Internal Medicine
Biddeford, Maine, United States
Great Lakes Heart Center of Alpena
Alpena, Michigan, United States
Internal Medicine of Northern Michigan
Petoskey, Michigan, United States
Minneapolis VAMC
Minneapolis, Minnesota, United States
Central Minnesota Heart Center at St. Cloud Hospital
Saint Cloud, Minnesota, United States
St. Paul Cardiology
Saint Paul, Minnesota, United States
Glacier View Cardiology, PC
Kalispell, Montana, United States
Impact Clinical Trials
Las Vegas, Nevada, United States
NJ Heart
Linden, New Jersey, United States
New Jersey Physicians
Passaic, New Jersey, United States
Lifeline Research Institute
Brooklyn, New York, United States
Metrolina Internal Medicine, PA
Charlotte, North Carolina, United States
Heart Care Center of Charlotte
Charlotte, North Carolina, United States
Physicians East, PA
Winterville, North Carolina, United States
Plaza Medical Group, PC
Oklahoma City, Oklahoma, United States
Castlerock Clinical Research Consultants, LLC
Tulsa, Oklahoma, United States
Integrated Medical Research PC
Ashland, Oregon, United States
Blackstone Cardiology Associates
Pawtucket, Rhode Island, United States
Charleston Cardiology
Charleston, South Carolina, United States
Paris View Family Practice
Greenville, South Carolina, United States
Internal Medicine of Greer
Greer, South Carolina, United States
Scenic City Research
Cleveland, Tennessee, United States
Southeast Texas Clinical Research Center
Beaumont, Texas, United States
Cardiovascular Research Inst. of Dallas
Dallas, Texas, United States
Galenos Research
Dallas, Texas, United States
Sergio F Rovner, MD
El Paso, Texas, United States
Salim Gopalani, MD, PA
Houston, Texas, United States
Humayum Mirza, MD, PA
Houston, Texas, United States
Clinical Trial Network
Houston, Texas, United States
Houston Clinical Research Assoc.
Houston, Texas, United States
Innovative Research of West Florida
Hurst, Texas, United States
North Texas Medical Research
Plano, Texas, United States
Scott & White Memorial Hospital
Temple, Texas, United States
Fletcher Allen Health Care/University of Vermont
Burlington, Vermont, United States
Kamlesh N Dave Cardiology
Hopewell, Virginia, United States
WVU Physicicans of Charleston
Charleston, West Virginia, United States
Alpha Medical Research, LLC
Madison, Wisconsin, United States
Executive Health and Research Associates
Madison, Wisconsin, United States
Instituto de Investigaciones Clinicas Bahia Blanca
Bahía Blanca, , Argentina
Consultorios Medicos Privados S.A.
Buenos Aires, , Argentina
Policlinica Bancaria "9 de Julio"
Buenos Aires, , Argentina
Diabaid (Instituto de Asistencia Integral en Diabetes)
Ciudad de Buenos Aires, , Argentina
MD Investigaciones
Ciudad de Buenos Aires, , Argentina
Instituto de Cardiologia de Corrientes
Corrientes, , Argentina
Framingham Centro Medico
La Plata, , Argentina
Instituto de Investigaciones Clinicas Mar del Plata
Mar del Plata, , Argentina
Instituto de Investigaciones Clinicas de Quilmes
Quilmes, , Argentina
Instituto de Investigaciones Clinicas
Rosario, , Argentina
Centro de Investigaciones clincas de Litoral
Santa Fe, , Argentina
Flinders Medical Centre
Bedford, , Australia
Royal Perth Hospital
Perth, , Australia
Private Practice of Dr. Herwig Van Aerde
Rio de Janeiro, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Protocol DAR-312-E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.